CARPL.ai and Keya Medical Announce Strategic Partnership

Cupertino, California  – CARPL.ai and Keya Medical are excited to announce a strategic collaboration aimed at accelerating the integration of advanced AI solutions in clinical radiology workflows worldwide. This partnership will combine Keya Medical’s cutting-edge cardiovascular imaging technology with CARPL.ai’s leading vendor-neutral AI platform, enhancing diagnostic precision and clinical efficiency for healthcare providers.

CARPL.ai is the world’s largest radiology AI marketplace, offering over 175+ applications from 75+ AI vendors. With its unified user interface, single data channel, and streamlined procurement system, CARPL.ai empowers radiologists to easily access, assess, and integrate AI solutions into clinical practice.

“We are pleased to announce our partnership with Keya Medical to bring their advanced cardiac solution to clinicians across North America and the Asia-Pacific region. This collaboration underscores our mutual commitment to enhancing patient care through impactful and innovative technologies,” said Dhruv Sahai, COO, CARPL.

Through this collaboration, Keya Medical will leverage CARPL.ai’s platform to broaden the reach of its advanced cardiovascular solutions, allowing healthcare professionals to seamlessly incorporate AI-powered diagnostics into their daily workflows. This partnership will also foster joint research initiatives and enable the deployment of innovative AI tools that drive better patient outcomes.

“Our collaboration with CARPL.ai marks a significant step toward enhancing global access to cutting-edge AI-driven cardiovascular solutions,” said Nathan Qin, Global Business Advisory Board member at Keya Medical. “Together, we aim to empower radiologists with tools that improve diagnostic accuracy and patient care on a global scale.”

This strategic partnership underscores both organisations’ commitment to advancing AI adoption in healthcare and supporting clinicians in delivering faster, more accurate diagnoses.